Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia

European Journal of Pharmacology

Volumn 259, Issue 2, 1994, Pages 115-120

  Pertwee, Roger ^a   Griffin, Graeme ^a   Hanuš, Lumir ^b   Mechoulam, Raphael ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Anandamide; Cannabinoid; endogenous; mouse; Tolerance; Vas deferens; 9 Tetrahydrocannabinol

Indexed keywords

ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; DRONABINOL; DRUG RECEPTOR; FATTY ACID ETHANOLAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SYNTHESIS; DRUG TOLERANCE; ELECTROSTIMULATION; MALE; MOUSE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; VAS DEFERENS;

ANIMAL; DRUG INTERACTIONS; DRUG TOLERANCE; ELECTRIC STIMULATION; ETHANOLAMINES; FATTY ACIDS, UNSATURATED; IN VITRO; MALE; MICE; MUSCLE CONTRACTION; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TETRAHYDROCANNABINOL; VAS DEFERENS;

EID: 0028226120     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(94)90499-5     Document Type: Article

References (15)

1. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
2. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
3. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction
4. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent
5. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor
6. The cannabinoid receptor
7. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells
8. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
9. Aminoalkylindoles: actions on specific G-protein-linked receptors
10. The evidence for the existence of cannabinoid receptors
11. Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine
12. 9-tetrahydrocannabinol and the cannabimimetic agents CP 55, 940, WIN 55,212-2 and anandamide
13. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase
14. 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats